1 / 2

Cervical Cancer Treatment Market Size, Growth Report 2022

Cervical cancer is of three types Squamous cell carcinoma, Cervical Adenocarcinoma, and Adenosquamous carcinoma. About 9 out of 10 cervical cancers are squamous cell carcinomas. These cancers develop from cells in the exocervix while cervical adenocarcinoma develops from the mucus-producing gland cells of the endocervix. The incidence of adenocarcinoma is rising predominantly in younger girls.

Shalini11
Télécharger la présentation

Cervical Cancer Treatment Market Size, Growth Report 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Cervical Cancer Treatment Market size is projected to reach USD billion by 2029, with growth at a CAGR of 5% during the forecasting period (2022-2029). Cervix is the lower part of the uterus that connects to vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, are responsible for 90% of cervical cancers. The market is driven by the increased prevalence of cervical cancer, proactive government initiatives, awareness among people, new advancements in targeted therapies, and a strong pipeline of drugs. Cervical Cancer Treatment Market is segmented By Type of Cancer (Squamous Cell Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Combined Therapy). North America was the dominant region in the global cervical cancer treatment market and is expected to continue its dominance over the forecast period. Geographically, the global market is divided into five major regions such as; •North America •Latin America •Europe •Asia Pacific •Middle East and Africa •Rest of the global countries Some of the major Companies Leading the Global Market: 1.F. Hoffmann-LA Roche AG 2.Merck & Co., Inc 3.GlaxoSmithKline PLC 4.Allergan PLC 5.Pfizer, Inc. 6.Biocon Ltd 7.Bristol-Myers Squibb Company 8.AstraZeneca PLC 9.CooperSurgical, Inc 10.Ethicon, Inc 11.Eli Lilly & Co 12.Teva Pharmaceutical Industries Ltd 13.Varian Medical Systems, Inc. Download Sample Report @ https://www.datamintelligence.com/download-sample/cervical-cancer- treatment-market Additional Benefits Post Purchase: 1) Unlimited Analyst support for a period of 1 year. 2) Any query with regard to the scope offered will be addressed within 24- 48 hours.

  2. 3) An excel sheet with market numbers will be provided separately About Us: DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages among others. Contact Information: Sai Kiran DataM Intelligence 4Market Research LLP +1 877-441-4866 info@datamintelligence.com

More Related